Chandler Robinson - Chief Executive Officer, Director at Monopar Therapeutics

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
MNPR on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Chandler Robinson since 10/30/2023

Holdings reported by Chandler Robinson for Monopar Therapeutics

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 56.2K $379K $6.74 Sep 30, 2024 Direct
Common Stock 33.3K $225K $6.74 Sep 30, 2024 Indirect
Restricted Stock Units 29.8K $201K $6.74 Sep 30, 2024 Direct Common Stock
Stock Options 0 May 28, 2024 Direct Common Stock

Transactions reported by Chandler Robinson for Monopar Therapeutics

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.